Your Source for Venture Capital and Private Equity Financings

Venture Capital News: SpyGlass Pharma Scores $90M Series C

2023-07-10
ALISO VIEJO, CA, SpyGlass Pharma, a company developing a treatment for glaucoma and other chronic ophthalmic diseases, announced a $90 million Series C funding round.
SpyGlass Pharma, a company developing a treatment for glaucoma and other chronic ophthalmic diseases, announced a $90 million Series C funding round led by RA Capital Management alongside existing investors New Enterprise Associates and Vensana Capital, as well as new investors Samsara BioCapital and Vertex Ventures HC.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors